City
Epaper

Researchers investigate why some people feel motion sickness while playing VR games while others do not

By ANI | Updated: May 2, 2023 20:25 IST

Washington [US], May 2 : The way our senses adapt when playing high-intensity virtual reality games is crucial in ...

Open in App

Washington [US], May 2 : The way our senses adapt when playing high-intensity virtual reality games is crucial in understanding why some individuals suffer from severe cybersickness while others do not.

Cybersickness is a form of motion sickness that occurs from exposure to immersive VR and augmented reality applications.

A new study, led by researchers at the University of Waterloo, found that the subjective visual vertical a measure of how individuals perceive the orientation of vertical lines shifted considerably after participants played a high-intensity VR game.

"Our findings suggest that the severity of a person's cybersickness is affected by how our senses adjust to the conflict between reality and virtual reality," said Michael Barnett-Cowan, a professor in the Department of Kinesiology and Health Sciences. "This knowledge could be invaluable for developers and designers of VR experiences, enabling them to create more comfortable and enjoyable environments for users."

The researchers collected data from 31 participants. They assessed their perceptions of the vertical before and after playing two VR games, one high-intensity and one low-intensity.

Those who experienced less sickness were more likely to have the largest change in the subjective visual vertical following exposure to VR, particularly at a high intensity. Conversely, those who had the highest levels of cybersickness were less likely to have changed how they perceived vertical lines. There were no significant differences between males and females, nor between participants with low and high gaming experience.

"While the subjective vertical visual task significantly predicted the severity of cybersickness symptoms, there is still much to be explained," said co-author William Chung, a former Waterloo doctoral student who is now a postdoctoral fellow at the Toronto Rehabilitation Institute.

"By understanding the relationship between sensory reweighting and cybersickness susceptibility, we can potentially develop personalized cybersickness mitigation strategies and VR experiences that take into account individual differences in sensory processing and hopefully lower the occurrence of cybersickness."

As VR continues to revolutionize gaming, education and social interaction, addressing the pervasive issue of cybersickness marked by symptoms such as nausea, disorientation, eye strain and fatigue is critical for ensuring a positive user experience.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: WaterlooUniversity Of WaterlooDepartment of kinesiology and health sciencesWilliam chungusUs Secretary Of StateUs National Public RadioUs State DepartmentUs ArmyUs Department Of CommerceUs Food And Drug AdministrationUs DefenceUs Justice DepartmentUs District Court
Open in App

Related Stories

InternationalIndian-Origin Man Beheaded In US In Front Of Family After Violent Dispute

BusinessAnil Ambani’s Reliance Power and Reliance Infra Shares Zoom Even as Indian Markets Tumble Amid US Tariffs

InternationalMissouri House Blast: 5 Injured After Huge Explosion Damages 20 Homes in St Louis County

InternationalHurricane Erin Enters Into Category 2 Storm With Maximum Winds of 100 mph, Heavy Rainfall Over Caribbean Islands Likely

InternationalIowa Shooting: Two Killed, One Injured In Firing and Blast in Glenwood; Suspect Arrested

Health Realted Stories

HealthRajasthan govt bans cough syrup after patients fall ill in Bharatpur and Sikar

HealthScience innovation accelerates development: MP Minister

HealthCardiology Beyond Stents - How Terna Hospital Manages Heart Failure Holistically

HealthNew blood test to predict risk of liver cirrhosis, cancer within 10 years

HealthIndia must ensure equitable, timely access to lenacapavir to tackle global HIV cases